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Abstract
Peroxisome proliferators are potent rodent liver carcinogens that act via a non-genotoxic mechanism.
The mode of action of these agents in rodent liver includes increased cell proliferation, decreased
apoptosis, secondary oxidative stress and other events; however, it is not well understood how
peroxisome proliferators are triggering the plethora of the molecular signals leading to cancer.
Epigenetic changes have been implicated in the mechanism of liver carcinogenesis by a number of
environmental agents. Short-term treatment with peroxisome proliferators and other non-genotoxic
carcinogens leads to global and locus-specific DNA hypomethylation in mouse liver, events that
were suggested to correlate with a burst of cell proliferation. In the current study, we investigated
the effects of long-term exposure to a model peroxisome proliferator WY-14,643 on DNA and histone
methylation. Male SV129 mice were fed a control or WY-14,643-containing (1000 ppm) diet for 1
wk, 5 wks or 5 months. Treatment with WY-14,643 led to progressive global hypomethylation of
liver DNA as determined by an HpaII-based cytosine extension assay with the maximum effect
reaching over 200% at 5 months. Likewise, trimethylation of histone H4 lysine 20 and H3 lysine 9
was significantly decreased at all time points. The majority of cytosine methylation in mammals
resides in repetitive DNA sequences. In view of this, we measured the effect of WY-14,643 on the
methylation status of major and minor satellites, as well as in IAP, LINE1 and LINE2 elements in
liver DNA. Exposure to WY-14,643 resulted in a gradual loss of cytosine methylation in major and
minor satellites, IAP, LINE1 and LINE2 elements. The epigenetic changes correlated with the
temporal effects of WY-14,643 on cell proliferation rates in liver, but no sustained effect on c-Myc
promoter methylation was observed. Finally, WY-14,643 had no effect on DNA and histone
methylation status in Pparα-null mice at any of the time points considered in this study. These data
indicate the importance of epigenetic alterations in the mechanism of action of peroxisome
proliferators and the key role of PPARα.
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Recent evidence shows that epigenetic changes play an important role in carcinogenesis
induced by a variety of factors that act via either genotoxic or non-genotoxic mechanisms [1,
2]. Genotoxic carcinogens or products of their metabolic activation interact with DNA directly
causing tumor formation [3], whereas non-genotoxic carcinogens are a diverse group of
chemicals that induce neoplastic cell transformation by mechanisms other than direct DNA
damage [4]. One of the most extensively studied classes of non-genotoxic carcinogens are
peroxisome proliferators, a structurally diverse group of chemicals and therapeutic agents
[5]. Long-term exposure to these chemicals results in the development of liver tumors in male
and female mice and rats [6,7]. The mode of action of peroxisome proliferators in rodent liver
includes increased cell proliferation, decreased apoptosis, secondary oxidative stress, and other
events [8]. It is widely recognized that the molecular target for their action in liver is the
peroxisome proliferators-activated receptor (PPAR)α, and most of the effects, including the
hepatocarcinogenic response, are the result of a PPARα-mediated mechanism [9,10]. However,
it is not well understood how peroxisome proliferators are triggering the plethora of molecular
signals leading to cancer in rodent liver and why prolonged activation of PPARα-induced
pathways leads to hepatocarcinogenesis.
Short-term treatment with non-genotoxic rodent carcinogens, including peroxisome
proliferators, is known to lead to hypomethylation of DNA and proto-oncogenes in mouse
liver, events that were suggested to correlate with a burst of cell proliferation [11-13]. Our
previous studies using a methyl-deficient model of non-genotoxic hepatocarcinogenesis in rats
showed that alteration of cellular epigenetic processes, such as DNA hypomethylation and loss
of histone H4 lysine 20 trimethylation, are key steps in the carcinogenic process induced by
methyl deficiency [14,15]. Additionally, it has been demonstrated recently that global DNA
hypomethylation was associated with the development of multiple liver tumors, while
protecting from colon tumors, in Apc(Min/+)/Dnmt1(chip/c) mice providing additional
evidence for the importance of epigenetic alterations in the origin of liver tumors [16]. These
findings have led to a suggestion that sensitivity to tumorigenesis may be inversely related to
the capacity to maintain normal patterns of the cellular epigenetic landscape [17].
In order to further characterize the long-term epigenetic effects of peroxisome proliferators in
mouse liver and their dependence upon PPARα, we examined the hypothesis that epigenetic
dysregulation is an important contributing factor to the mechanisms of carcinogenicity of these
agents. The effects of WY-14,643, a model peroxisome proliferator, were examined in wild
type or Pparα-null mice treated for up to 5 months. Global methylation of DNA, histone
modification changes and other endpoints were evaluated.
Materials and Methods
Animals and Treatments
Pparα-null male mice (SV129 background; [18]), and corresponding wild type counterparts
(6−8 weeks of age at the beginning of treatment) were used. Animals were housed in sterilized
cages in a facility with a 12-hr night/day cycle. Temperature and relative humidity were held
at 22±2°C and 50±5%, respectively. The UNC Division of Laboratory Animal Medicine
maintains these animal facilities, and veterinarians were always available to ensure animal
health. All animals were given humane care in compliance with NIH and institutional
guidelines and studies were performed according to protocols approved by the appropriate
institutional review board. Prior to experiments, animals were maintained on standard lab chow
diet and purified water ad libitum. 4-Chloro-6-(2,3-xylidino)-pyrimidynylthioacetic acid
(WY-14,643) was obtained from Aldrich (Milwaukee, WI). NIH-07 was used as the base for
the pelleted diet (prepared by Harlan Teklad, Indianapolis, IN) containing either 0 ppm
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(control), or 1000 ppm of WY-14,643. Dietary concentration of WY-14,643 was measured by
high performance liquid chromatography after the pellets were made and determined to be
±18% of the target concentration. Diet was administered ad libitum for 1 week, 5 weeks or 5
months. Animals had free access to water throughout the study and the health status of the
animals was monitored every second day throughout the study. At sacrifice, mice were
anesthetized with pentobarbital (100 mg/kg, i.p.) and following exsanguination livers were
removed, weighed, placed in microcentrifuge tubes and snap frozen in liquid nitrogen. The
samples were stored at −80°C until assayed.
Global DNA methylation analysis
The extent of the global DNA methylation was evaluated with a radiolabeled [3H]dCTP
extension assay as described previously [19]. Briefly, 1 μg of genomic DNA was digested with
20 U of methylation-sensitive HpaII restriction endonuclease (New England Biolabs, Beverly,
MA) for 16−18 h at 37°C. A second DNA aliquot (1 μg) was digested with methylation-
insensitive iso-schizomer MspI, which cleaves CCGG sites in DNA regardless of CpG
methylation status, to serve as a control for the digestion efficiency. Undigested DNA served
as a background control. The single nucleotide extension reaction was performed in a 25 μl
reaction mixture containing 1.0 μg DNA, 1X PCR buffer, 1.0 mM MgCl2, 0.25 U AmpliTaq
DNA polymerase (Applied Biosystems, Foster City, CA), 0.1 μl of [3H]dCTP (57.4 Ci/mmol;
Perkin Elmer, Boston, MA) and incubated at 56°C for 1 h. Samples were applied to DE-81
ion-exchange filters and washed three times with 0.5 M sodium phosphate buffer (pH 7.0) at
room temperature. The filters were dried and processed for scintillation counting. [3H]dCTP
incorporation into DNA is expressed as mean disintegrations per minute (dpm) per μg of DNA
after subtraction of the dpm incorporation in undigested samples (background).
Methylation-sensitive arbitrarily primed PCR
The methylation status of GC-rich regions was determined by using the methylation-sensitive
arbitrarily primed PCR (ms-AP-PCR) assay as described previously [20]. Briefly, 1 μg of
genomic DNA was separately digested with 20 U each of methylation-insensitive endonuclease
RsaI and methylation-sensitive endonuclease HpaII (New England Biolabs) at 37°C for 16−18
h. Restriction-digested DNA was amplified using AP-PCR with single MLG2 primer [19],
which hybridized preferentially to GC-rich regions in the presence of [33P] dCTP (Perkin
Elmer). PCR products were resolved on 5% polyacrylamide 7 M urea sequencing gel. Gel-
resolution of amplified PCR products resulted in the generation of methylation-sensitive
fingerprints. After electrophoresis, the gel was analyzed by Cyclone Storage Phosphor Screen
system (Packard Instrument, Meriden, CT) for differences in the intensity of bands between
control and WY-14,643-treated samples. Relative decrease in the intensity of a bands or the
disappearance/appearance of a band in WY-14,643-treated samples as compared to control
samples is interpreted as a loss of methylation/hypermethylation, respectively. The band
intensities were quantified as described elsewhere [21].
The methylation changes within unmethylated DNA domains were determined by using the
McrBC-msAP-PCR as described previously [22]. This technique allows detection of
differentially methylated sites within unmethylated DNA domains enriched by regulatory
sequences and CpG islands. Briefly, 2 μg of genomic DNA was digested overnight at 37°C in
presence of 10 U/μg DNA of McrBC endonuclease (New England Biolabs). McrBC is a
methylation-specific endonuclease, which, as opposed to methylation-sensitive restriction
endonucleases, cleaves DNA containing 5-methylcytosine on one or both strands but does not
act on unmethylated DNA. Additionally, it does not recognize HpaII sites (CCGG) in which
the internal cytosine is methylated. McrBC-digested DNA fragments were separated on a 1%
agarose gel, and DNA fragments larger than 1 kb were excised from the gel and purified by
using a QIAquick Gel Extraction kit according to manufacturer's protocol (Qiagen, Valencia,
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CA). The fragments, which were enriched for unmethylated DNA, were then digested
overnight with 20 U/μg DNA of methylation-sensitive restriction endonuclease SmaI (New
England Biolabs), followed by digestion with 20 U/μg DNA of HpaII (New England Biolabs).
The digested DNA was amplified by PCR and analyzed as detailed above.
Analysis of methylation status of DNA repetitive elements and c-Myc promoter
DNA methylation analysis of repetitive elements in mouse genome was performed by using
the quantitative McrBC-PCR assay as described previously [23]. Cleavage of methylated DNA
by McrBC induces DNA strand breaks and abrogates PCR amplification. Conversely, the
presence of unmethylated cytosines in DNA prevents enzyme cleavage and can be detected by
PCR amplification product recovery. Undigested DNA served as control. Following the
McrBC treatment, subsequent PCR was used to amplify the intracisternal A particle (IAP) of
long terminal repeats (LTR) retrotransposons and long interspersed nucleotide elements 2
(LINE2) representing the non-LTR retrotransposons. The quantitative aspect of the procedure
was verified by a linear increase in PCR product recovery with increasing cycle number and
DNA template concentration. The results were confirmed by quantitative real-time PCR using
a SYBR GreenER SuperMix (Invitrogen, Carlsbad, CA) for iCycler (Bio-Rad, Hercules, CA).
Methylated DNA sequences have decreased amount of PCR product after McrBC digestion.
The results are presented as relative change in ratio of PCR product recovery after digestion
of DNA with McrBC relative to undigested DNA.
The methylation status of LINE1 was determined by the COBRA assay [24], which consists
of a standard bisulfite modification of genomic DNA, subsequent PCR amplification and
digestion of the PCR product with the appropriate restriction endonuclease. The combination
of sodium bisulfite treatment and PCR amplification results in methylation-dependent retention
of preexisting restriction endonuclease sites, or methylation-dependent creation of new sites.
Briefly, 2 μg of genomic DNA was treated with sodium bisulfite, and bisulfite-modified DNA
was PCR amplified with primers corresponding to the regulatory region of mouse LINE1
sequence. The sense primer was 5'-GATTAAGACGTATTAAGAAAT-3', and the antisense
primer was 5'-TTTGTAAGAAGATTTCGTTTAGTTA-3'. The PCR products were digested
with 20 units of HpyCH4IV endonuclease (New England Biolabs). The digested PCR products
were separated on a 3% high-resolution agarose gel (Sigma, St. Louis, MO), stained with
ethidium bromide, photographed, and the band intensity was analyzed by ImageQuant software
(Molecular Dynamics, Sunnyvale, CA).
The methylation status of c-Myc promoter was determined by the quantitative McrBC-PCR
assay [23] with primers corresponding to the regulatory region of mouse c-Myc gene. The sense
primer was 5'-GGTGACTGATATACGCAGGGCAAGA-3', and the antisense primer was 5'-
CCGGGGAAAGAGGAGGAGGAG-3'.
Analysis of histone H3 and histone H4 modifications
Acidic cell extracts were prepared from liver tissue as described previously [25]. Equal amount
of total histones (40 μg) was mixed with two volumes of gel loading buffer (250 mM Tris-HCl
(pH 8.0), 20% β-mercaptoethanol, 40% glycerol, 8% SDS, and 1.2 mg/ml bromophenol blue),
heated for 5 min at 95°C, and resolved on 15% polyacrylamide gels. Proteins were transferred
onto PVDF membranes (GE Healthcare Biosciences, Piscataway, NJ). The membranes were
blocked for 4 h in Tris-buffered saline (TBS) containing 5% nonfat dry milk and 0.1%
Tween-20. Primary antibodies against trimethyl-histone H3 lysine 9 (H3K9me3), and
trimethyl-histone H4 lysine 20 (H4K20me3) were diluted 1:1000 and 1:2000, respectively,
according to manufacturer's recommendations (Upstate, Charlottesville, VA). Primary
antibody binding was performed at 4°C overnight with constant shaking. A secondary donkey
anti-rabbit antibody, labeled with alkaline phosphatase (Santa Cruz Biotechnology, Santa Cruz,
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CA), was applied at 1:5000 dilutions and binding was carried out at room temperature for 1.5
h. Chemifluorescence detection was performed with the ECF Substrate for Western Blotting
(GE Healthcare Biosciences) and measured directly by Storm Imaging System (Molecular
Dynamics). Images are representative of three independent immunoblots and were analyzed
by ImageQuant software (Molecular Dynamics). All membranes were stained with Coomassie
Blue and with anti-histone H3 and anti-histone H4 antibodies to confirm equal protein loading.
Statistical analysis
Results are presented as mean ± S.D. and were assessed by 2-way analysis of variance
(ANOVA), using treatment and weeks as fixed factors, or one-way ANOVA, using treatment
as the fixed factor. When necessary to maintain equal variance or normal data distribution, the
results were ln transformed before conducting the ANOVA. p-Values <0.05 were considered
significant.
Results
Chronic treatment with WY-14,643 causes a progressive PPARα-dependent loss of global
DNA methylation in mouse liver
Continuous exposure to WY-14,643 at the dose level used in this study (1000 ppm) results in
a 100% incidence of hepatocellular adenomas and carcinomas in wild type mice after about
11 months [9]. In this study, DNA methylation status was assessed in livers of wild type and
Pparα-null mice fed WY-14,643-containing diet for up to 5 months. In wild type mice treated
with WY-14,643 for 1 week, 5 weeks, or 5 months liver cell proliferation was elevated about
3-, 13- and 22-fold (as compared to time-matched mice fed control diet), respectively, and no
liver tumors were detected [26]. WY-14,643 had no effect on liver cell proliferation in
Pparα-null mice [26]. A cytosine extension assay that measures the proportion of unmethylated
CpG sites in genomic DNA was used to assess effects of the treatment. The assay is based on
the ability of the HpaII methylation-sensitive restriction enzyme to cleave unmethylated CCGG
sequences and leave a 5' guanine overhang that can be used for the subsequent single nucleotide
extension with labeled [3H]dCTP [19]. The extent of [3H]dCTP incorporation is directly
proportional to the number of unmethylated CCGG sites. Figure 1 (top graph) shows that long-
term administration of WY-14,643-containing diet led to a progressive demethylation of
genomic DNA in wild type mice, evident from an increase in incorporation of [3H]dCTP into
HpaII-digested DNA. In contrast, no treatment-related effects, except for non-significant
transient DNA hypomethylation at 5 weeks, were evident in Pparα-null mice fed with
WY-14,643 (Figure 1, bottom graph). While many factors may lead to ephemeral changes in
DNA methylation, only sustained effects are generally considered as important in
carcinogenesis [14].
WY-14,643 induces region-specific DNA methylation changes in mouse liver
Mammalian genome consists of short (< 4kb) un-methylated domains embedded into longer
methylated domains [25]. To determine whether the effects of WY-14,643 on global
methylation in mouse liver are domain-specific, we measured methylation changes in
methylated and largely un-methylated regions separately. First, we used ms-AP-PCR
fingerprint analysis to determine methylation changes within methylated domains in the liver
of wild type mice in response to feeding WY-14,643-containing diet. Progressive WY-14,643-
induced hypomethylation occurs evenly within all methylated DNA domains, as evidenced by
the decrease in the intensity of bands or the disappearance of a band compared to control
samples (Figure 2, left panel). Quantification of band intensity for 15 regions with most
prominent changes (Figure 2, left panel, arrows) indicated significant time-dependent
hypomethylation in liver DNA at all locations evaluated by this assay (data not shown). The
un-methylated domains in mammalian genome are frequently located in regulatory regions
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that are enriched in CpG islands [25]. To assess the potential effect of WY-14,643 on
methylation in these regions, we used a modified (with a restriction enzyme McrBC) ms-AP-
PCR. In contrast to significant changes in constitutively methylated DNA (Figure 2, left panel),
the methylation status of un-methylated domains was not altered by WY-14,643 in any of the
time points assessed (Figure 2, right panel).
Effect of WY-14,643 on methylation status of DNA repetitive elements in mouse liver
The majority of CpG methylation in mammalian cells is located in repetitive DNA elements
[27] and one of the main functions of DNA methylation proteins in somatic cells is to maintain
stability of the genome by silencing the expression of these repetitive sequences [28]. It has
been suggested that genome-wide DNA hypomethylation in cancer cells and during
carcinogenesis largely affect methylation status of these repetitive sequences [28]. The mouse
genome consists of almost 19% of non-long terminal repeat (LTR) retrotransposons or LINE1
elements, which form the single largest fraction of interspersed repeats [23]. Furthermore, LTR
retrotransposons, including the highly active intracisternal A-particle (IAP) elements, account
for over 10% of all spontaneous mutations in mice [23]. Thus, we measured the effect of long
term exposure to WY-14,643 on methylation status of these repetitive elements in mouse liver.
Treatment with WY-14,643 resulted in a progressive decrease of LINE1, LINE2 and LTR IAP
methylation (Figure 3). In addition, hypomethylation of major and minor satellites was also
observed in liver of WY-14,643-treated wild type mice (data not shown). Interestingly,
methylation of c-Myc gene was not affected by long-term dietary treatment with WY-14,643
even though WY-14,643-related hypomethylating effect on c-Myc gene early after a single
dose of WY-14,643 has been observed [11].
Effect of WY-14,643 on histones in mouse liver
Histone methylation is an important component of maintaining genome stability. To determine
the effects of long-term dietary exposure to WY-14,643 on methylation status of histones H3
and H4, we assessed the content of trimethylated histones in livers of wild type and Pparα-
null mice treated for up to 5 months. A rapid and sustained loss of histone H3K9 and histone
H4K20 trimethylation was observed in the wild type mice fed WY-14,643-containing diet
(Figure 4, top panel). The level of histone H3K9me3 and H4K20me3 in liver of the wild type
mice after only 1 week of treatment was ∼55% and 63% lower, respectively, than in control
group, and remained suppressed for up to 5 months. In contrast, the level of H3K9me3 and
H4K20me3 were not affected in Pparα-null mice at any of the time points (Figure 4, bottom
panel). To determine the possible mechanism for the loss of H3K9 and H4K20 trimethylation
in the liver of wild type mice fed WY-14,643-containing diet, we assessed the protein levels
of the major histone methyltransferases Suv39h1, PRDM/Riz1 (both responsible for histone
H3K9 trimethylation [29]), and Suv4−20h2 (histone H4K20 trimethylation [30]). WY-14,643
had no effect on Suv39h1, while expression of PRDM/Riz1 increased significantly as early as
1 week of treatment and remained elevated for up to 5 months (Figure 5). The effect on
expression of Suv420h2 was more gradual and the amounts of this protein in livers of mice
fed WY-14,643 was lower than in control animals.
Discussion
This study shows that long-term dietary administration of WY-14,643 leads to prominent
epigenetic changes in mouse liver. These effects included progressive loss of global DNA
methylation, hypomethylation of mobile repetitive DNA elements, and loss of histone H3K9
and H4K20 trimethylation accompanied by diminished protein levels of Suv4−20h2 histone
methyltransferase. In contrast, WY-14,643 exposure had no effect on global DNA methylation
or trimethylation of histones in liver of Pparα-null mice indicating that epigenetic effects of
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peroxisome proliferators, like many other liver-specific molecular changes caused by these
agents in rodents, are mediated through a PPARα-dependent mechanism.
It is well established that tumorigenesis is associated with alterations in cellular epigenetic
status, especially with hypomethylation of DNA [31,32]. Genome-wide loss of DNA
methylation have been regarded as a common event in cancer cells [32]. Recent studies have
suggested a link between long-term exposure to carcinogens, epigenetic alterations, and the
ensuing malignant transformation [1,2]. Specifically, studies show that a sustained loss of DNA
methylation in liver is an early and indispensable event in hepatocarcinogenesis induced by
long-term exposure to both genotoxic and non-genotoxic agents in rodents [14,17,21,25].
Furthermore, it has been hypothesized that sensitivity to tumorigenesis may be inversely related
to the capacity to maintain normal patterns of DNA methylation [17]. In view of this, the
progressive hypomethylation of DNA in the liver of WY-14,643-exposed wild type mice may
be considered an important factor in mechanism of PP-induced rodent carcinogenesis.
It has been suggested that peroxisome proliferator-induced increases in liver cell proliferation
would prevent the methylation of the newly synthesized strands of DNA [11]. This hypothesis
was supported by the fact that after a single administration of WY-14,643 to mice the temporal
relationship between increased cell proliferation and DNA hypomethylation of the c-Myc gene
was observed. Our data shows that long-term treatment with WY-14,643 produces a pattern
of gradually worsening dysregulation of normal methylation patterns in genomic DNA and
histones and that these effects correlate with constitutively increasing cell proliferation in liver
at these time points [26]. Indeed, it was shown that the ability of DNA methyltransferase 1,
the most abundant DNA methyltransferase in somatic cells, to maintain sufficient methylation
status of CpG-rich domains is limited under conditions of such elevated rates of DNA synthesis
[33]. Several possible alternative explanations exist for the mechanism of DNA
hypomethylation after exposure to WY-14,643. First, long-term exposure to peroxisome
proliferators leads to secondary oxidative stress in liver [34,35] which may result in oxidative
damage of methylated cytosine residues and depletion in the level of 5-methylcytosine in DNA
[36]. Second, formation of high levels of oxidative stress-induced DNA adducts like 8-
hydroxydeoxyguanosine and 5-hydroxymethylcytosine is known to facilitate DNA hypo-
methylation by preventing methylation of the target cytosine by DNA methyltransferase 1
[37,38], or by significantly inhibiting protein binding to the methylated CpG islands [36].
Third, activation of base excision repair, especially long-patch base excision DNA repair,
which plays a predominant role in the removal of oxidative stress-induced DNA lesions and
was shown to be induced following long-term treatment with peroxisome proliferators [39]
could also lead to genome-wide hypomethylation.
We observed no effect on c-Myc promoter methylation with continuous exposure for 1 week
or more, in contrast to the effects of a single dose of WY-14,643 [11]. Thus, alterations in the
genome methylation patterns with continuous exposure to non-genotoxic liver carcinogens,
such as WY-14,643, may not be confined to specific cell proliferation-related genes. It has
been shown that genome-wide DNA hypomethylation in cancer, including liver cancer, largely
affects repetitive DNA elements [28,40,41]. Additionally, recent evidence indicates that
hypomethylation of retroelements occurs even in precancerous stages of development of
human hepatocellular carcinoma [41,42], as well as at early stages of non-genotoxic and
genotoxic rodent hepatocarcinogenesis [43,44]. Loss of cytosine methylation at repetitive
DNA sequences is associated with increased transcription of these elements. In view of this,
our observation of hypomethylation of LTR IAP, LINE1 and LINE2 retrotrasposons following
long-term exposure to WY-14,643 may be an evidence of their reactivation, which in turn
would have an effect on the stability of the genome. Furthermore, emerging evidence suggests
a crucial role of histone H3 lysine 9 and H4 lysine 20 trimethylation in the maintenance of
genomic stability [30]. One of the primary functions of H3K9me3 and H4K20me3 is the
Pogribny et al. Page 7













formation of constitutive heterochromatin and trimethylation of H3K9 and H4K20 is
considered a prominent epigenetic mark of silenced heterochromatin. Major and minor
satellites and LINE1 retrotransposons in mouse genome are predominantly enriched with
H3K9me3 and H4K20me3, and trimethylation of H4K20 is the sole prominent mark for LTR
IAP [23]. Loss of H3K9 and H4K20 trimethylation is known to be associated with activation
of LTR IAP and LINE1 transcription [23], increased genomic and chromosomal instability,
and increased tumor incidence [40,45]. Additionally, loss of H4K20me3 compromises the
ability of the DNA damage checkpoint control [46], and loss of H3K9me3 compromises the
balance between cell proliferation and differentiation processes favoring cell proliferation
[47]. In addition, considering the critical role of histone methyltransferases in the preservation
of chromatin structure [30], our observations of the retained expression of Suv39h1 and
increased levels of PRDM/Riz protein under conditions of the loss in histone H3K9 and H4K20
trimethylation and diminished Suv4−20h2 expression may be interpreted as a cellular defense
mechanism for maintenance of heterochromatin organization and liver cell viability.
In conclusion, WY-14,643-induced loss of global and repeat-associated DNA
hypomethylation, loss of H3K9 and H4K20 trimethylation, and diminished expression of Suv4
−20h2 histone methyltransferase in liver of wild type mice may be evidence of compromised
genomic integrity via chromatin decondensation, activation of mobile repetitive DNA elements
resulting in a variety of genomic instability events including cis- and trans-insertional
mutagenesis, unequal homologous recombination, rearrangements, and segmental duplications
leading to deletions and duplications [48]. The causal role of these lesions as an integral part
of neoplastic transformation in the etiology of cancer is now commonly accepted [49].
Furthermore, lack of effect of WY-14,643 on DNA and histone methylation in Pparα-null mice
suggests that methylation changes are dependent upon PPAPα-mediated events in rodent liver,
such as cell proliferation and oxidative stress to DNA. Since it is widely believed that humans
are not at risk for PPARα-mediated liver cancer [8] this study provides important information
that distinguishes the relevance and the potential role of epigenetic factors in the mechanism
of action of peroxisome proliferators in mice, species which are susceptible to
hepatocarcinogenesis by these agents, and humans.
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Figure 1. Long-term treatment with WY-14,643 leads to progressive loss of global DNA methylation
in the liver of wild type, but not Pparα-null mice
DNA methylation in liver of WY-14,643 (1000 ppm)-exposed wild type (top panel) and
Pparα-null (bottom panel) mice and age-matched control mice was measured by the cytosine
extension assay as detailed in Methods. The extent of [3H]dCTP incorporation is directly
proportional to the number of unmethylated CCGG sites. Data is presented as mean±S.D. for
each group (n=5) and asterisks (*) indicate significant difference from time/strain-matched
control mice.
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Figure 2. Region-specific effects of WY-14,643 on DNA methylation status in mouse liver
Representative ms-AP-PCR (left panel) and McrBC-ms-AP-PCR (right panel) fingerprints of
methylation status of highly methylated (left) and unmethylated (right) DNA regions from
livers of control (one sample each from 1 week and 5 month groups) and WY-14,643-fed mice.
Relative decrease in the intensity or disappearance of each band (arrows), as compared to
corresponding control, is an evidence for loss of methylation. The results were reproduced in
two independent experiments with all samples. Two samples from each time point are shown.
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Figure 3. Effects of WY-14,643 on methylation status of LINE1, LINE2, and LTR IAP
retrotransposons and c-Myc gene in mouse liver
The status of LINE1 methylation (top panel) was evaluated using COBRA assay with the
HpyCH4IV restriction endonuclease. The data is presented as ratio between uncut and
HpyCH4IV-cut fragments in liver of WY-14,643-fed mice and the age-matched control mice.
The increased ratio between undigested and HpyCH4IV -digested PCR products rats indicates
the loss of LINE-1 methylation. The status of LINE2 and LTR IAP (middle two panels), and
c-Myc promoter (lower panel) methylation was evaluated by quantitative McrBC-PCR assay.
The results are presented as ratio of PCR product recovery between McrBC-digested DNA and
undigested DNA. Increase in McrBC-digested DNA/undigested DNA ratio is indicative of
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hypomethylation status. Data is presented as mean±S.D. for controls (all time points, n=15)
and each treatment group (n=5). Asterisks (*) indicate significant difference from time/strain-
matched control mice. Representative PCR images are shown.
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Figure 4. Long-term treatment with WY-14,643 leads to progressive loss of histone H4K20me3 and
H3K9me3 in the liver of wild type, but not Pparα-null mice
Acid extracts of total histones prepared from livers of wild type (top panel) or Pparα-null
(bottom panel) mice were separated by SDS-PAGE and subjected to immunoblotting using
specific antibodies against histone H3K9me3 and histone H4K20me3 as detailed in Methods.
Results (mean±S.D.) are presented as change in methylation in each treatment group (n=5)
relative to control mice (all time points, n=15). Equal sample loading was confirmed by
immunostaining against histone H3 and histone H4. Representative immunoblot images are
shown. Asterisks (*) indicate significant difference from time/strain-matched control mice.
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Figure 5. Effects of WY-14,643 on expression of Suv39h1, Suv4−20h2, and PRDM/Riz1 histone
methyltransferases in mouse liver
Liver tissue lysates were separated by SDS-PAGE and subjected to immunoblotting using
specific antibodies against Suv39h1, Suv4−20h2, and PRDM/Riz1 histone methyltransferases.
Equal sample loading was confirmed by immunostaining against β-actin. Bar graph shows
quantitative evaluation (percent change, mean±S.D.) of the Suv39h1, Suv4−20h2, and PRDM/
Riz1 expression in livers of WY-14,643-treated mice (n=5 for each time point) relative to those
in control animals (all time points, n=15). Representative Western immunoblot images from
two independent experiments are shown for each protein. Asterisks (*) indicate significant
difference from time/strain-matched control mice.
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